Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day
Shares of Bristol Myers Squibb Co. BMY slumped 0.55% to $58.37 Wednesday, on what proved to be an all-around great trading ...
Big hedge funds call on doctors, scientists for pharma stock edge
Some of the world’s largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...
News Medical9h
American Heart Association launches initiative to improve hypertrophic cardiomyopathy care
An estimated 1 in 500 people in the U.S. are living with hypertrophic cardiomyopathy (HCM) -; the most common inherited heart disease -; and many are unaware.
Hosted on MSN12h
Is Bristol-Myers Squibb Stock Outperforming the Nasdaq?
Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in ...
labiotech13h
Idiopathic pulmonary fibrosis: Refoxy, Boehringer, Insilico, and more on the hunt for curative treatments
Research in idiopathic pulmonary fibrosis is progressing rapidly, with the goal of delivering more treatments to patients at ...
From Contagious to Chronic: Growing Health Crisis in Low- and Middle-Income Countries
Low- and middle-income countries (LMICs) are undergoing a significant health transformation. While once predominantly ...
Taiwan News23h
CAR-T Cell Therapy Market Size, Segmentation along with Opportunities, Gross Margin and Forecast 2025-2033
Global CAR-T Cell Therapy Market Zooms 6.2X to Touch Whopping USD 57 Billion by 2030. Global CAR-T Cell Therapy Market is thriving due to increasing prevalence of cancer, a spurri ...